发明申请
- 专利标题： NK1 Antagonists
- 专利标题（中）： NK1拮抗剂
-
申请号： US13245403申请日： 2011-09-26
-
公开(公告)号： US20120295879A1公开(公告)日： 2012-11-22
- 发明人: Anandan Palani , Xianhai Huang , Dong Xiao , Sapna S. Shah , Sunil Paliwal , Hon-Chung Tsui , Michelle Laci Wrobleski , Ashwin U. Rao , Cheng Wang , Neng-Yang Shih
- 申请人： Anandan Palani , Xianhai Huang , Dong Xiao , Sapna S. Shah , Sunil Paliwal , Hon-Chung Tsui , Michelle Laci Wrobleski , Ashwin U. Rao , Cheng Wang , Neng-Yang Shih
- 申请人地址： US FL Miami
- 专利权人： OPKO HEALTH, INC.
- 当前专利权人： OPKO HEALTH, INC.
- 当前专利权人地址： US FL Miami
- 主分类号： A61K31/454
- IPC分类号： A61K31/454 ; A61K31/4523 ; A61K31/451 ; A61P25/22 ; A61K31/573 ; A61P1/18 ; A61P11/14 ; A61P25/24 ; A61K31/4545 ; A61K31/56
摘要：
A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
公开/授权文献
- US08754216B2 NK1 antagonists 公开/授权日：2014-06-17
信息查询
IPC分类:
